Increasing trends in kidney cancer over the last 2 decades in Saudi Arabia

References

1. 1.↵
   1. Chow WH,
   2. Dong LM,
   3. Devesa SS

   (2010) Epidemiology and risk factors for kidney cancer. Nature Reviews Urology 7:245–257.

   OpenUrl
2. 2.↵
   1. Chow WH,
   2. Devesa SS,
   3. Warren JL,
   4. Fraumeni JF Jr.

   (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628–1631.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Linehan JA,
   2. Nguyen MM

   (2009) Kidney cancer: the new landscape. Curr Opin Urol 19:133–137.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Gupta NP,
   2. Ishwar R,
   3. Kumar A,
   4. Dogra PN,
   5. Seth A

   (2010) Renal tumors presentation: changing trends over two decades. Indian J Cancer 47:287–291.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Nalavenkata S,
   2. Jarvis TR,
   3. Rashid P

   (2011) Incidental small renal mass: current management. ANZ J Surg 81:797–803.

   OpenUrlPubMed
6. 6.↵
   1. Washio M,
   2. Mori M,
   3. Mikami K,
   4. Miki T,
   5. Watanabe Y,
   6. Nakao M,
   7. et al.

   (2014) Risk factors for renal cell carcinoma in a Japanese population. Asian Pac J Cancer Prev 15:9065–9070.

   OpenUrlPubMed
7. 7.↵
   1. Sivaramakrishna B,
   2. Gupta NP,
   3. Wadhwa P,
   4. Hemal AK,
   5. Dogra PN,
   6. Seth A,
   7. et al.

   (2005) Pattern of metastases in renal cell carcinoma: a single institution study. Indian J Cancer 42:173–177.

   OpenUrlPubMed
8. 8.
   1. Singam P,
   2. Ho C,
   3. Hong GE,
   4. Mohd A,
   5. Tamil AM,
   6. Cheok LB,
   7. et al.

   (2010) Clinical characteristics of renal cancer in Malaysia : a ten year review. Asian Pac J Cancer Prev 11:503–506.

   OpenUrlPubMed
9. 9.↵
   1. Jewett MA,
   2. Mattar K,
   3. Basiuk J,
   4. Morash CG,
   5. Pautler SE,
   6. Siemens DR,
   7. et al.

   (2011) Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 60:39–44.

   OpenUrlCrossRefPubMed
10. 11.↵
    1. Hollingsworth JM,
    2. Miller DC,
    3. Daignault S,
    4. Hollenbeck BK

    (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98:1331–1334.

    OpenUrlCrossRefPubMedWeb of Science
11. 12.↵
    1. Kane CJ,
    2. Mallin K,
    3. Ritchey J,
    4. Cooperberg MR,
    5. Carroll PR

    (2008) Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113:78–83.

    OpenUrlPubMed
12. 13.↵
    1. McLaughlin JK,
    2. Chow WH,
    3. Mandel JS,
    4. Mellemgaard A,
    5. McCredie M,
    6. Lindblad P,
    7. et al.

    (1995) International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 63:216–221.

    OpenUrlCrossRefPubMedWeb of Science
13. 14.↵
    1. Fryzek JP,
    2. Poulsen AH,
    3. Johnsen SP,
    4. McLaughlin JK,
    5. Sørensen HT,
    6. Friis S

    (2005) A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer 92:1302–1306.

    OpenUrlCrossRefPubMedWeb of Science
14. 15.↵
    1. Frank I,
    2. Blute ML,
    3. Leibovich BC,
    4. Cheville JC,
    5. Lohse CM,
    6. Zincke H

    (2005) Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 173:1889–1892.

    OpenUrlCrossRefPubMedWeb of Science
15. 16.↵
    1. Mancuso A,
    2. Sternberg CN

    (2006) New treatment approaches in metastatic renal cell carcinoma. Curr Opin Urol 16:337–341.

    OpenUrlPubMed
16. 17.↵
    1. Kanao K,
    2. Mizuno R,
    3. Kikuchi E,
    4. Miyajima A,
    5. Nakagawa K,
    6. Ohigashi T,
    7. et al.

    (2009) Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification. J Urol 181:480–485.

    OpenUrlPubMedWeb of Science
17. 18.↵
    1. Lane BR,
    2. Kattan MW

    (2008) Prognostic models and algorithms in renal cell carcinoma. Urol Clin North Am 35:613–625.

    OpenUrlCrossRefPubMedWeb of Science
18. 19.↵
    1. Boffetta P,
    2. Hashibe M

    (2006) Alcohol and cancer. Lancet Oncol 7:149–156.

    OpenUrlCrossRefPubMedWeb of Science
19. 20.↵
    1. Behrens G,
    2. Leitzmann MF

    (2013) The association between physical activity and renal cancer: systematic review and meta-analysis. Br J Cancer 108:798–811.

    OpenUrlCrossRefPubMedWeb of Science
20. 21.↵
    1. Paz-Filho G,
    2. Lim EL,
    3. Wong ML,
    4. Licinio J

    (2011) Associations between adipokines and obesity-related cancer. Front Biosci (Landmark Ed) 16:1634–1650.

    OpenUrl
21. 22.↵
    1. Weber JS,
    2. Levit LA,
    3. Adamson PC,
    4. Bruinooge S,
    5. Burris HA,
    6. Carducci MA,
    7. et al.

    (2015) American Society of Clinical Oncology Policy Statement Update: The Critical Role of Phase I Trials in Cancer Research and Treatment. J Clin Oncol 33:278–284.

    OpenUrlFREE Full Text
22. 23.↵
    1. Al-Rubeaan KA,
    2. Youssef AM,
    3. Subhani SN,
    4. Ahmad NA,
    5. Al-Sharqawi AH,
    6. Ibrahim HM

    (2013) A Web-based interactive diabetes registry for health care management and planning in Saudi Arabia. J Med Internet Res 15:e202.

    OpenUrl
23. 24.↵
    1. Albejaidi FM

    (2010) Healthcare system in Saudi Arabia: An analysis of structure, total quality management and future challenges. Journal of Alternative Perspectives in the Social Sciences 2:794–818.

    OpenUrl
24. 25.↵
    1. World Health Orgzanization

    Country Cooperation Strategy for WHO and Saudi Arabia 2012-2016 (WHO, Geneva (CH)) 2013, Available from URL: http://www.who.int/countryfocus/cooperation_strategy/ccs_sau_en.pdf.